Olive (Clearinghouse and Patient Access)
Enterprise Systems (Healthcare)
Olive (Clearinghouse and Patient Access) valuation and funding history | Last updated: October 31, 2023 | 1 funding rounds
Current Valuation
N/A
As of October 31, 2023
Total Funding Raised
N/A
Across 1 round
Last Round
Buyout/LBO (Add-on)†
Amount undisclosed
Last Funding
Oct 2023
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| October 31, 2023 | Buyout/LBO (Add-on)† | Undisclosed | N/A | - |
Valuation Analysis
Current Valuation Metrics
Olive (Clearinghouse and Patient Access) is currently valued at N/A as of October 31, 2023.
Explore More Data
Detailed analysis for Olive (Clearinghouse and Patient Access)
What is Olive (Clearinghouse and Patient Access) Worth in 2026?
Olive (Clearinghouse and Patient Access) is a leading private company in the Enterprise Systems (Healthcare) sector. Track Olive (Clearinghouse and Patient Access)'s valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Olive (Clearinghouse and Patient Access) Valuation is Determined
Private company valuations like Olive (Clearinghouse and Patient Access)'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.